Gelsolin: A novel thyroid hormone receptor-β interacting protein that modulates tumor progression in a mouse model of follicular thyroid cancer

Endocrinology

Volumn 148, Issue 3, 2007, Pages 1306-1312

  Kim, Caroline S ^a   Furuya, Fumihiko ^a   Ying, Hao ^a   Kato, Yasuhito ^a   Hanover, John A ^b   Cheng, Sheue Yann ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GELSOLIN; SMALL INTERFERING RNA; THYROID HORMONE RECEPTOR BETA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARBOXY TERMINAL SEQUENCE; CARCINOGENESIS; CELL MOTILITY; CHEMICAL ANALYSIS; CONTROLLED STUDY; CYTOSKELETON; DNA BINDING; DNA MICROARRAY; DOWN REGULATION; HORMONE ACTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INTERACTION; THYROID CANCER; THYROID FOLLICULAR CARCINOMA; THYROID GLAND; TUMOR CELL; TUMOR GROWTH; WILD TYPE;

ACTINS; ANIMALS; CARCINOMA, PAPILLARY, FOLLICULAR; CELL MOVEMENT; CELLS, CULTURED; CERCOPITHECUS AETHIOPS; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; GELSOLIN; MICE; MICE, TRANSGENIC; MUTANT PROTEINS; PROTEIN BINDING; THYROID GLAND; THYROID HORMONE RECEPTORS BETA; THYROID NEOPLASMS;

EID: 33847030012     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2006-0923     Document Type: Article

References (27)

1. Schlumberger MJ 1998 Papillary and follicular thyroid carcinoma. N Engl J Med 338:297-306
2. Suzuki H, Willingham MC, Cheng SY 2002 Mice with a mutation in the thyroid hormone receptor β gene spontaneously develop thyroid carcinoma: a mouse model of thyroid carcinogenesis. Thyroid 12:963-969
3. Yen PM 2003 Molecular basis of resistance to thyroid hormone. Trends Endocrinol Metab 14:327-333
4. Parrilla R, Mixson AJ, McPherson JA, McClaskey JH, Weintraub BD 1991 Characterization of seven novel mutations of the c-erbAβ gene in unrelated kindreds with generalized thyroid hormone resistance. Evidence for two "hot spot" regions of the ligand binding domain. J Clin Invest 88:2123-2130
5. Meier CA, Dickstein BM, Ashizawa K, McClaskey JH, Muchmore P, Ransom SC, Menke JB, Hao EH, Usala SJ, Bercu BB 1992 Variable transcriptional activity and ligand binding of mutant β1 3,5,3′-triiodothyronine receptors from four families with generalized resistance to thyroid hormone. Mol Endocrinol 6:248-258
6. Ying H, Suzuki H, Furumoto H, Walker R, Meltzer P, Willingham MC, Cheng SY 2003 Alterations in genomic profiles during tumor progression in a mouse model of follicular thyroid carcinoma. Carcinogenesis 24:1467-1479
7. Ying H, Suzuki H, Zhao L, Willingham MC, Meltzer P, Cheng SY 2003 Mutant thyroid hormone receptor β represses the expression and transcriptional activity of peroxisome proliferator-activated receptor γ during thyroid carcinogenesis. Cancer Res 63:5274-5280
8. McGough AM, Staiger CJ, Min JK, Simonetti KD 2003 The gelsolin family of actin regulatory proteins: modular structures, versatile functions. FEBS Lett 552:75-81
9. Kwiatkowski DJ 1999 Functions of gelsolin: motility, signaling, apoptosis, cancer. Curr Opin Cell Biol 11:103-108
10. De Corte V, Bruyneel E, Boucherie C, Mareel M, Vandekerckhove J, Gettemans J 2002 Gelsolin-induced epithelial cell invasion is dependent on Ras-Rac signaling. EMBO J 21:6781-6790
11. Winston JS, Asch HL, Zhang PJ, Edge SB, Hyland A, Asch BB 2001 Down-regulation of gelsolin correlates with the progression to breast carcinoma. Breast Cancer Res Treat 65:11-21
12. Moriya S, Yanagihara K, Fujita H, Kuzumaki N 1994 Differential expression of HSP90, gelsolin and GST-p in human gastric carcinoma cell lines. Int J Oncol 5:1347-1351
13. Furuuchi K, Fujita H, Tanaka M, Shichinohe T, Senmaru N, Ogiso Y, Moriya S, Hamada M, Kato H, Kuzumaki N 1997 Gelsolin as a suppressor of malignant phenotype in human colon cancer. Tumor Target 2:277-283
14. Dosaka-Akita H, Hommura F, Fujita H, Kinoshita I, Nishi M, Morikawa T, Katoh H, Kawakami Y, Kuzumaki N 1998 Frequent loss of gelsolin expression in non-small cell lung cancers of heavy smokers. Cancer Res 58:322-327
15. Tanaka M, Mullauer L, Ogiso Y, Fujita H, Moriya S, Furuuchi K, Harabayashi T, Shinohara N, Koyanagi T, Kuzumaki N 1995 Gelsolin: a candidate for suppressor of human bladder cancer. Cancer Res 55:3228-3232
16. Lee HK, Driscoll D, Asch H, Asch B, Zhang PJ 1999 Downregulated gelsolin expression in hyperplastic and neoplastic lesions of the prostate. Prostate 40:14-19
17. Visapaa H, Bui M, Huang Y, Seligson D, Tsai H, Pantuck A, Figlin R, Rao JY, Belldegrun A, Horvath S, Palotie A 2003 Correlation of Ki-67 and gelsolin expression to clinical outcome in renal clear cell carcinoma. Urology 61:845-850
18. Aldred MA, Ginn-Pease ME, Morrison CD, Popkie AP, Gimm O, Hoang-Vu C, Krause U, Dralle H, Jhiang SM, Plass C, Eng C 2003 Caveolin-1 and caveolin-2, together with three bone morphogenetic protein-related genes, may encode novel tumor suppressors down-regulated in sporadic follicular thyroid carcinogenesis. Cancer Res 63:2864-2871
19. Kaneshige M, Kaneshige K, Zhu XG, Dace A, Garrett L, Carter TA, Kazlauskaite R, Pankratz DG, Wynshaw-Boris A, Refetoff S, Weintraub B, Willingham MC, Barlow C, Cheng SY 2000 Mice with a targeted mutation in the thyroid hormone β receptor gene exhibit impaired growth and resistance to thyroid hormone. Proc Natl Acad Sci USA 97:13209-13214
20. Furumoto H, Ying H, Chandramouli GV, Zhao L, Walker RL, Meltzer PS, Willingham MC, Cheng SY 2005 An unliganded thyroid hormone β receptor activates the cyclin D1/cyclin-dependent kinase/retinoblastoma/E2F pathway and induces pituitary tumorigenesis. Mol Cell Biol 25:124-135
21. Kim CS, Vasko VV, Kruhlak M, Saji M, Cheng SY, Ringel MD 2005 AKT activation promotes metastasis in a mouse model of follicular thyroid carcinoma. Endocrinology 146:4456-4464
22. Yap N, Yu CL, Cheng SY 1996 Modulation of the transcriptional activity of thyroid hormone receptors by the tumor suppressor p53. Proc Natl Acad Sci USA 93:4273-4277
23. Nishimura K, Ting HJ, Harada Y, Tokizane T, Nonomura N, Kang HY, Chang HC, Yeh S, Miyamoto H, Shin M, Aozasa K, Okuyama A, Chang C 2003 Modulation of androgen receptor transactivation by gelsolin: a newly identified androgen receptor coregulator. Cancer Res 63:4888-4894
24. Rabié A, Ferraz C, Clavel MC, Legrand C 1988 Gelsolin immunoreactivity and development of the tectorial membrane in the cochlea of normal and hypothyroid rats. Cell Tissue Res 254:241-245
25. Dong Y, Asch HL, Ying A, Asch BB 2002 Molecular mechanism of transcriptional repression of gelsolin in human breast cancer cells. Exp Cell Res 276:328-336
26. Silacci P, Mazzolai L, Gauci C, Stergiopulos N, Yin HL, Hayoz D 2004 Gelsolin superfamily proteins: key regulators of cellular functions. Cell Mol Life Sci 61:2614-2623
27. Archer SK, Claudianos C, Campbell HD 2005 Evolution of the gelsolin family of actin-binding proteins as novel transcriptional coactivators. Bioessays 27:388-396